Abstract
New strategy for the synthesis of 2-(2,3,6,9-tetrahydro-1,3-dimethyl-2,6-dioxo-1H-purin-8-yl)acetonitrile through a molecular linking with pyridopyrimidine, pyrazolopyridine, and pyranonapthyridine derivatives. The newly synthesized compounds were characterized on the basis of spectral (FT-IR, 1H, 13C NMR, Mass spectral) analyses and further screened for their antimicrobial, antioxidant, and anticancer properties. Compound 6a indicated a higher activity against Gram-negative bacteria and compound 7d toward Gram-positive bacteria. Antifungal validation of the compounds revealed 7b as sensible against Aspergillus niger, Aspergillus oryzae, Candida albicans, and Penicillium chrysogenum at all concentrations. Compound 6b showed prominent cytotoxic activity with IC50 (µM) values of 0.8 ± 0.61, 1.0 ± 0.3, 1.2 ± 0.7, and 0.90 ± 0.71 against MCF-7, A-549, HeLa, and Panc-1 cancer cell lines, respectively. Compounds 6c and 10c showed significant antioxidant activity at all concentrations with ED50 values (3.39 ± 0.3 and 4.27 ± 0.5 μM, respectively). Further, docking was performed at the 1SA5 active site to anticipate their conceivable binding mode by compound 6b. Graphical Abstract

This publication has 50 references indexed in Scilit: